“…Pyridinophane 3,6,9,15-tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene (L, Figure 1 ) is a member of this family that was first synthesised in 1981 [ 5 ]. It was later in the spotlight for its ability to form metal complexes [ 6 , 7 , 8 ], but its wider success was achieved thanks to its utilisation as a scaffold for the preparation of new materials that have proven effective in a variety of applications. Indeed, L derivatives decorated with different hanging functionalities have been studied for several biomedical (MRI contrast agents [ 9 , 10 , 11 , 12 ], antiproliferative treatments [ 13 , 14 , 15 , 16 ], radiotherapy [ 17 , 18 ], enzyme mimicking [ 19 , 20 ] and antioxidant activity [ 21 , 22 , 23 ]), chemosensing [ 24 , 25 , 26 , 27 ] and catalytic [ 28 , 29 , 30 , 31 , 32 , 33 ] applications.…”